There are disclosed novel heterocyclic anthracycline compounds having antitumor activity against murine P388 leukemia in mice, processes for preparing the novel compounds and pharmaceutical compositions containing them. The novel compounds have the formula:
wherein R is hydrogen or hydroxy and X, Y or Z may be sulfur with the proviso that when X is sulfur then Y and Z are both CH and when Y is sulfur then X and Z are both CH and when Z is sulfur then X and Y are both CH, or the formula:
wherein R is hydrogen or hydroxy and M is a heterocyclic moiety such as
and
本发明公开了对小鼠 P388 白血病具有抗肿瘤活性的新型杂环
蒽环类化合物、制备新型化合物的工艺以及含有这些化合物的药物组合物。这些新型化合物的
化学式如下
其中 R 是氢或羟基,X、Y 或 Z 可以是
硫,但条件是当 X 是
硫时,Y 和 Z 都是 CH;当 Y 是
硫时,X 和 Z 都是 CH;当 Z 是
硫时,X 和 Y 都是 CH,或式:
其中 R 是氢或羟基,M 是杂环分子,如
和